Bioequivalence and Bioavailability Forum • within subject standard deviation in fully replicate design if carry over effect is present

within subject standard deviation in fully replicate design if carry over effect is present [General Statistics]

posted by dshah – India, 2023-06-14 12:37 (709 d 08:31 ago) – Posting: # 23591
Views: 3,086

Hello Ankit!

As per PSG, the recommendation is parallel study.

[image]

[image]

❝ So how to calculate Swr when unequal carryover effect is present in full replicate study design?

Moreover, the study population is patient and you can not stop the treatment. So why fully replicate CO study?

Regards,
Divyen

Complete thread:

within subject standard deviation in fully replicate design if carry over effect is present Ankit Parikh 2023-06-08 13:54
- within subject standard deviation in fully replicate design if carry over effect is present dshah 2023-06-08 16:35
  - within subject standard deviation in fully replicate design if carry over effect is present Ankit Parikh 2023-06-09 07:15
    - within subject standard deviation in fully replicate design if carry over effect is present dshah 2023-06-14 09:26
      - within subject standard deviation in fully replicate design if carry over effect is present Ankit Parikh 2023-06-14 09:33
        
        within subject standard deviation in fully replicate design if carry over effect is presentdshah 2023-06-14 10:37

Admin contact
23,424 posts in 4,927 threads, 1,682 registered users;
45 visitors (0 registered, 45 guests [including 29 identified bots]).
Forum time: 21:08 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body. Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz